dicer
dicer
endoribonucleas
member
rnase
iii
famili
encod
dicer
gene
function
cleav
long
doublestrand
rna
premirna
sirna
mirna
base
pair
length
nt
overhang
end
microrna
mirna
mirna
kind
nt
small
noncod
rna
fragment
discov
virus
plant
anim
human
function
posttranscript
regul
gene
express
protein
plant
tombusviru
kda
protein
rna
silenc
suppressor
protein
select
bind
exactli
match
doublestrand
antivir
sirna
nt
imperfectli
pair
mirna
ssrna
dsrna
prokaryot
sirna
prosirna
prosirna
bacteri
rnase
iii
product
chemic
function
properti
similar
eukaryot
sirna
ribonucl
acid
rna
rna
linear
molecul
compos
four
type
smaller
molecul
call
ribonucleotid
base
adenin
cytosin
c
guanin
g
uracil
u
comprehens
biotechnolog
edit
volum
rna
depend
rna
polymeras
rdrp
rdrp
enzym
use
rna
templat
catalyz
rna
synthesi
replic
rna
induc
silenc
complex
risc
risc
multiribonucleoprotein
complex
whole
structur
unsolv
associ
trbp
protein
three
dsrna
bind
domain
argonaut
protein
catalyt
center
risc
employ
one
singlestrand
rna
small
dsrna
fragment
sirna
mirna
templat
recogn
complementari
mrna
argonaut
protein
induc
cleavag
suppress
mrna
transcript
result
rna
interfer
rna
interfer
ribonucl
acid
interfer
rnai
biolog
process
rna
molecul
inhibit
gene
express
translat
neutral
target
mrna
molecul
short
hairpin
rna
shrna
shrna
artifici
molecul
consist
two
complementari
nt
rna
sequenc
link
nt
short
loop
nt
overhang
end
similar
premirna
socal
stemloop
structur
small
interf
rna
sirna
sirna
sometim
known
short
interf
rna
class
doublestrand
rna
molecul
base
pair
length
similar
mirna
oper
within
rnai
pathway
origin
discoveri
rnai
relev
phenomenon
retrospect
napoli
jorgensen
claim
transgeneinduc
cosuppress
endogen
chalcon
synthas
gene
gener
hybrid
violet
petunia
later
similar
phenomenon
observ
romano
macino
neurospora
crassa
describ
quell
endogen
gene
caus
introduct
homolog
rna
sequenc
howev
rnai
event
anim
first
report
caenorhabd
elegan
guo
kemphu
note
introduc
sens
antisens
rna
lead
degrad
mrna
time
homolog
antisens
rna
regard
tool
silenc
hybrid
endogen
mrna
form
doublestrand
rna
stop
translat
guo
kemphu
use
sens
rna
hybrid
capac
endogen
transcript
valid
interestingli
degrad
mrna
still
observ
result
rais
question
uncertainti
potenti
regul
mechan
remain
undiscov
follow
investig
paradox
find
fire
mello
publish
paper
state
possibl
explan
cosuppress
quell
sens
mrna
endogen
gene
c
elegan
model
employ
purifi
singlestrand
rna
ssrna
doublestrand
rna
dsrna
target
mrna
gene
dsrna
consist
demonstr
higher
efficaci
either
ssrna
gene
silenc
result
individu
whole
popul
propos
dsrna
could
trigger
stoichiometr
implic
integr
endogen
mrna
vivo
possibl
catalyt
amplif
compon
play
highlight
role
interfer
process
region
develop
system
silenc
effect
requir
stabl
intermedi
system
hamilton
baulcomb
first
demonstr
exist
stabl
intermedi
system
plant
support
hypothesi
suggest
dsrna
need
unwind
antisens
rna
strand
serv
guid
bind
mrna
though
full
length
antisens
strand
never
found
estim
nt
antisens
rna
requir
specif
bind
base
observ
besid
anoth
two
differ
team
found
nt
rna
could
alway
purifi
drosophila
cell
rnai
propos
shorten
convert
dsrna
mediat
cleavag
target
transcript
research
use
nt
chemic
synthes
dsrna
determin
system
variou
speci
find
short
dsrna
mediat
gene
silenc
also
exist
mammalian
cell
ambro
group
found
gene
encod
short
tempor
matur
rna
length
nt
c
elegan
short
rna
identifi
mirna
follow
investig
show
genom
sequenc
tend
form
hairpin
loop
stemloop
sequenc
precursor
rna
sourc
mirna
mirna
demonstr
gene
regul
effect
posttranscript
level
variou
speci
determin
substanc
directli
lead
gene
silenc
small
dsrna
small
dsrna
form
bernstein
team
discov
risc
respons
mrna
cleavag
could
collect
highspe
centrifug
wherea
short
convert
dsrna
fragment
still
remain
supernat
indic
initi
phase
dsrna
cleavag
sirna
effect
phase
mrna
cleavag
destruct
result
two
differ
enzymat
activ
hannon
group
hypothes
initi
phase
enzym
dsrna
ribonucleas
chose
differ
rnase
iii
famili
enzym
investig
use
epitop
tag
label
immunoprecipit
quantifi
nt
sirna
yield
differ
rnase
iii
enzym
found
enzym
encod
gene
regul
activ
name
dicer
sontheim
group
confirm
deplet
dicer
would
caus
loss
sirna
product
fail
induc
silenc
differ
target
gene
hand
initi
identif
risc
carri
tuschl
team
human
cervic
cancer
hela
cell
use
biotin
conjug
termin
sirna
order
coimmunoprecipit
whole
associ
protein
complex
argonaut
argonaut
isol
purif
joshuat
group
purifi
argonaut
protein
archebacterium
pyrococcu
furiosu
pfago
pfago
piwi
domain
share
high
similar
rnase
h
enzym
two
ident
dde
aspartateaspartateglutam
motif
catalyt
carboxyl
also
requir
cleavag
activ
rnase
h
base
result
joshuat
collabor
hannon
group
use
immunoprecipit
investig
complex
activ
cell
result
show
though
sirna
bound
ago
protein
complex
cleavag
activ
hannon
tri
mutat
key
amino
acid
piwi
domain
mutat
bind
sirna
cleavag
capac
besid
cleavag
activ
sirna
bind
risc
rais
great
research
interest
well
evid
show
singlestrand
sirna
found
within
risc
indic
potenti
unwind
bind
mechan
gregori
team
matranga
team
found
rna
helicas
function
unwind
duplex
sirna
employ
one
guid
strand
find
complementari
mrna
remain
antiguid
strand
cleav
remov
mechan
essenti
risc
activ
although
hold
function
cleav
sirna
target
mrna
protein
could
recruit
sirna
rnai
event
research
found
risc
compos
dicer
trbp
tar
rna
bind
protein
requir
trbp
help
recruit
dicer
complex
form
ternari
complex
induc
rnai
activ
effect
rnai
trigger
littl
induct
systemat
transmit
whole
organ
research
observ
recogn
rdrp
employ
aberr
accumul
rna
templat
gener
secondari
sirna
mrna
caus
sequenc
specif
degrad
process
name
transit
rdrp
play
import
role
variou
form
rnai
amplif
arabidopsi
unprim
rdrp
employ
mrna
cleav
fragment
substrat
produc
long
dsrna
dsrna
cut
dicer
gener
secondari
sirna
induc
mrna
degrad
c
elegan
differ
mechan
describ
unprim
rdrp
directli
use
primari
sirna
templat
substrat
transit
process
dicerindepend
secondari
sirna
directli
synthes
present
properti
sequenc
specif
degrad
mrna
upon
constantli
enrich
knowledg
risc
format
function
activ
understand
entir
rnai
conceptu
system
greatli
improv
investig
aim
crucial
compon
mrna
translat
regul
mrna
decay
center
quickli
carri
next
year
synthet
small
interf
rna
sirna
indispens
tool
investig
gene
function
eukaryot
cell
may
use
therapeut
purpos
knockdown
gene
implic
diseas
thu
far
synthet
sirna
produc
chemic
synthesi
elucid
rnai
machineri
emerg
twophas
mechanist
model
base
discoveri
studi
key
compon
regul
combin
includ
initi
phase
long
dsrna
cleav
nt
discret
small
rna
fragment
sirna
effector
phase
sirna
incorpor
multinucleas
complex
risc
induc
cleavag
degrad
homolog
mrna
initi
phase
sirna
gener
cleavag
long
dsrna
type
iii
endonucleas
dicer
fig
dicer
first
identifi
multidomain
rnase
enzym
drosophila
two
exist
form
produc
mirna
produc
sirna
share
structur
homolog
featur
display
differ
properti
like
atp
depend
substrat
specif
atp
independ
enzym
work
precursor
relat
mirna
biogenesi
previou
research
found
need
work
togeth
doublestrand
rna
bind
protein
dsrbdp
drosophila
dsrbdp
loquaci
loq
identifi
interact
coimmunoprecipit
experi
purifi
function
premirna
process
complex
contain
loq
complex
directli
activ
particip
premirna
process
activ
structur
analysi
show
loqspa
loqspb
among
loq
protein
speci
three
dsrna
bind
domain
dsrbd
loqspb
increas
affin
toward
premirna
atpdepend
enzym
show
substrat
specif
dsrna
share
structur
homolog
also
need
work
togeth
associ
form
function
heterodimer
complex
unlik
loq
two
dsrnabind
domain
interact
long
dsrna
regul
sirna
gener
activ
play
import
role
develop
stabil
demonstr
dsrna
bind
domain
essenti
process
complex
bind
sirna
load
risc
structur
analysi
show
rna
helicas
domain
domain
n
terminu
paz
domain
tandem
rnase
iii
motif
c
terminu
dsrbd
motif
sinc
alon
bind
sirna
indic
sirna
might
bind
interfac
trigger
conform
chang
complex
allow
coordin
bind
sirna
promot
assembl
sirisc
complex
effector
phase
singl
strand
sirna
mirna
work
guid
strand
incorpor
rnai
effector
rnainduc
silenc
complex
risc
cleav
mrna
repress
translat
rnainduc
transcript
silenc
rit
complex
regul
heterochromatin
assembl
fig
structur
analysi
show
risc
compos
paz
piwi
domain
ppd
protein
ppd
protein
amino
acid
paz
central
amino
acid
piwi
ctermin
research
found
ppd
protein
risc
ago
protein
ppd
protein
perform
differ
function
differ
system
exampl
ppd
c
elegan
respons
effici
sirna
mediat
mrna
cleavag
drosophila
mediat
incorpor
sirna
risc
homo
sapien
mrna
cleavag
requir
catalyt
activ
preliminari
investig
research
found
difficult
purifi
complet
eukaryot
ago
protein
figur
dsrna
shrna
mirna
precursor
cleav
dicer
drosha
produc
sirnamirna
duplex
amplif
process
induc
due
presenc
rnadepend
rna
polymeras
rdrp
short
dsrna
bind
effector
rnainduc
silenc
complex
risc
form
prerisc
holorisc
activ
effector
effect
remov
passeng
strand
recruit
mrna
directli
induc
cleavag
activ
mediat
translat
repress
chromatin
modif
subunit
risc
crystal
structur
fulllength
ago
protein
archebacterium
p
furiosu
pfago
determin
relationship
paz
piwi
identifi
function
domain
among
four
major
domain
sirna
bind
form
dicer
initi
complex
rdic
rnai
model
rdic
found
orient
bind
prefer
end
lower
melt
temperatur
sirna
duplex
tend
interact
less
stabl
end
stabl
end
sirna
tend
bind
result
hypothes
thermodynam
asymmetri
caus
separ
guid
strand
passeng
strand
investig
found
enzym
respons
risc
assembl
select
function
incorpor
sirna
strand
basi
structur
indic
sirna
structur
determin
orient
prefer
complex
result
select
guid
strand
incorpor
risc
complex
identifi
prerisc
contain
duplex
sirna
holorisc
character
risc
effect
remov
passeng
strand
studi
found
respons
convers
prerisc
holorisc
effici
rnai
requir
end
sirna
act
target
recognit
guid
catalyt
subunit
holorisc
rnase
h
like
activ
induc
cleavag
target
mrna
backbon
research
also
found
particular
gene
silenc
induc
small
induct
whole
organ
indic
potenti
amplif
mechan
rnadepend
rna
polymeras
rdrp
could
help
synthes
new
homolog
sequenc
recruit
destruct
target
amplif
process
rdrp
synthes
new
sirna
directli
use
introduc
sirna
templat
gener
long
dsrna
cleav
sirna
research
found
newli
synthes
sirna
fragment
nt
instead
nt
fragment
rejoin
product
cycl
long
dsrna
sustain
amplif
process
account
sequenc
specif
sirna
rnai
gener
consid
neg
switch
regul
express
gene
therefor
abl
introduc
vector
express
suitabl
rna
induc
rnai
includ
synthet
sirna
short
hairpin
rna
shrna
long
dsrna
endoribonucleaseprepar
short
interf
rna
prosirna
etc
first
two
singl
sequenc
other
multipl
sequenc
compar
featur
method
simpli
tabl
synthet
exogen
sirna
complet
basepair
nucleotid
nt
overhang
gener
chemic
synthet
polynucleotid
sequenc
design
effect
specif
sirna
key
success
gene
silenc
rnai
date
variou
sirna
design
algorithm
program
develop
wide
use
biologist
sirna
design
algorithm
certain
rule
call
tuschl
rule
base
paramet
includ
length
overhang
absenc
intron
region
gc
content
absenc
repeat
absenc
singl
nucleotid
polymorph
snp
site
homolog
gene
sequenc
rna
secondari
structur
etc
two
year
later
khvorova
et
al
suggest
thermodynam
properti
sirna
also
critic
part
determin
function
longev
involv
sirna
duplex
unwind
strand
select
year
develop
variou
webbas
program
design
sirna
candid
faculti
univers
hong
kong
combin
free
onlin
sirna
design
tool
togeth
develop
filter
algorithm
filter
ineffect
sirna
http
icshkuhksirnasoftwaresirnaphp
shown
mani
sirna
design
program
tend
select
differ
sirna
candid
rang
sirna
efficaci
even
though
run
algorithm
target
tabl
compar
differ
type
sirna
sequenc
recommend
use
two
sirna
design
program
compar
multipl
set
candid
search
optim
sirna
sequenc
sirna
specif
gene
obtain
effect
deliv
cell
three
effici
inexpens
deliveri
method
sirna
transfect
electropor
viral
vector
first
two
nonvir
deliveri
rest
one
name
impli
viral
deliveri
transfect
gener
three
mode
cation
liposom
polym
nanoparticl
lipid
conjug
rel
easi
transfect
sirna
cell
line
high
effici
reproduc
mani
commerci
reagent
offer
howev
suitabl
kind
cell
primari
cell
nondivid
cell
low
effici
vivo
hardtransfect
primari
cell
stem
cell
neuron
cell
electropor
anoth
intracellular
deliveri
method
could
good
choic
cell
membran
consist
phospholipid
bilay
suscept
electr
shock
power
voltag
puls
lipid
molecul
reorient
form
hydrophil
pore
let
nucleic
acid
via
electr
current
differ
cell
type
need
differ
optim
paramet
method
easier
make
cell
die
viralmedi
deliveri
similar
transduct
deliv
sirna
recombin
viral
vector
base
retroviru
adenoassoci
viru
aav
adenoviru
lentiviru
use
primari
nondivid
cell
compat
vivo
experi
stabl
express
problem
aris
lead
possibl
mutagen
immunogen
effect
need
gener
titrat
viral
particl
dr
mark
helm
groupmat
use
fluorescentlabel
sirna
trace
fate
subcellular
locat
synthet
sirna
result
fluoresc
reson
energi
transfer
fret
base
visual
sirna
get
cell
transloc
nucleu
reach
high
concentr
earli
time
point
reloc
cytoplasm
next
h
h
nearli
sirna
degrad
accord
rnai
activ
reach
peak
h
decreas
within
h
process
sirna
assembl
rnainduc
silenc
complex
risc
need
continu
process
tatrnabind
protein
trbp
pkr
activ
protein
pact
dicer
complex
need
shrna
long
dsrna
use
synthet
sirna
strongli
downregul
specif
gene
express
promis
method
howev
reduct
basic
transient
sinc
concentr
sirna
gradual
reduc
low
level
cell
divis
lead
ineffici
suppress
gene
express
especi
longliv
cell
reason
vectorbas
method
develop
gene
silenc
express
shrna
mediat
persist
suppress
gene
express
shrna
artifici
molecul
typic
consist
two
complementari
nt
rna
sequenc
link
nt
short
loop
nt
overhang
end
similar
premirna
socal
stemloop
structur
also
design
webbas
program
shrna
usual
deliv
gene
construct
consist
promotor
shrna
transcript
termin
sequenc
express
shrna
cell
achiev
deliveri
plasmid
viral
vector
bacteri
vector
transfect
use
introduc
plasmid
cell
similar
transfect
sirna
accomplish
use
commerci
transfect
reagent
vitro
use
vivo
viralmedi
deliveri
also
use
shrna
recombin
viral
vector
base
adenoassoci
viru
adenoviru
lentiviru
gene
construct
simpl
small
easili
insert
vector
genom
aav
adenovirus
episom
integr
genom
host
cell
addit
aav
diminish
pack
capac
limit
induct
immun
respons
host
cell
cell
divid
viru
lost
quickli
differ
aav
adenovirus
lentivirus
integr
genom
section
transcript
activ
chromatin
pass
progeni
increas
risk
insert
mutagenesi
kind
vector
use
deliveri
shrna
bacteri
vector
dr
shuanglin
xiang
cowork
engin
escherichia
coli
produc
plasmid
shrna
knock
gene
express
vitro
vivo
differ
sirna
shrna
synthes
nucleu
cell
vector
cell
gene
integr
host
genom
transcrib
pol
iii
pol
ii
depend
type
promot
shrna
induc
sustain
rnai
shrna
transport
cytoplasm
assimil
mirna
pathway
common
use
one
pol
iii
base
trna
promotor
promot
direct
high
level
shrna
express
afterward
mediat
highli
effici
gene
knockdown
howev
high
concentr
shrna
also
side
effect
increas
offtarget
possibl
lead
nonspecif
effect
interferon
respons
cellular
toxic
lack
cell
specif
compar
pol
iii
pol
ii
may
use
direct
cellor
tissuespecif
gene
silenc
shrna
effici
sirna
sirna
effect
concentr
knock
target
gene
usual
nanomolar
level
less
five
copi
shrna
suffici
integr
host
genom
even
though
mani
research
still
studi
improv
efficaci
replac
polymeras
iii
highli
effici
polymeras
ii
overexpress
exportin
express
multipl
shrna
singl
plasmid
vector
shrna
also
limit
due
advantag
stabl
express
use
gener
stabl
knockdown
cell
line
project
timeconsum
task
sinc
design
gene
construct
select
shrnaposit
cell
seen
mechan
rnai
long
dsrna
effect
induc
rnai
also
good
idea
synthes
long
dsrna
vitro
instanc
drosophila
dsrna
bp
even
longer
shown
trigger
gene
silenc
effect
fit
mammal
long
dsrna
activ
express
gene
interferon
pathway
includ
gene
encod
dsrnaactiv
protein
kinas
pkr
inhibit
translat
phosphoryl
eukaryot
initi
factor
asubunit
induc
transcript
inflammatori
gene
oligoadenyl
synthetas
oa
caus
nonspecif
effect
activ
rnase
l
result
termin
two
protein
synthes
final
caus
cell
death
sinc
activ
sirna
target
differ
sequenc
profound
differ
expens
cost
synthes
sirna
although
suppress
select
gene
express
without
trigger
interferon
respons
altern
method
use
bacteriophag
promot
mediat
transcript
linear
dna
templat
obtain
long
dsrna
develop
popular
one
use
rna
polymeras
deepen
research
mani
biochem
research
result
show
rnai
complet
multicompon
nucleas
function
complex
guid
small
guid
strand
nt
sirna
result
biochem
fraction
genet
approach
nucleas
call
dicer
rnase
iii
famili
identifi
cleav
dsrna
sirna
vitro
dicer
kit
alreadi
commerci
genlanti
method
cheaper
obtain
larg
number
sirna
dr
dongho
kim
cowork
found
dsrna
greater
potenc
synthet
nt
sirna
direct
target
site
properti
seem
correl
length
increas
length
sirna
synthet
rna
duplex
nt
length
potent
especi
duplex
length
nt
maxim
inhibitori
nt
induc
interferon
activ
protein
kinas
r
pkr
mean
synthet
rna
substrat
dicer
potent
convent
rna
possibl
increas
length
sirna
duplex
unprocess
end
thermodynam
stabl
prompt
incorpor
dicertrbppact
complex
effici
risc
assembl
although
dicer
enzym
also
involv
dsrna
cleavag
vivo
use
vitro
ineffici
especi
short
dsrna
dr
dun
yang
groupmat
report
similar
method
use
e
coli
rnase
iii
process
dsrna
esirna
said
method
effici
former
escherichia
coli
rnase
iii
dsrnaspecif
endoribonucleas
easili
produc
larg
scale
digest
dsrna
small
piec
bp
unabl
trigger
immunolog
respons
mammalian
cell
although
length
fragment
differ
tradit
sirna
end
structur
phosphat
hydroxyl
termini
nt
overhang
end
structur
report
import
rnai
activ
commerci
e
coli
rnase
iii
invitrogen
rnai
first
discov
c
elegan
use
tool
sever
year
name
rnai
initi
rnai
perform
microinject
correspond
dsrna
worm
observ
phenotyp
chang
parent
progeni
year
lisa
timmon
andrew
fire
found
c
elegan
show
genespecif
manner
depend
dsrna
exposur
environ
c
elegan
normal
feed
bacteria
suck
pharynx
subsequ
digest
gut
thu
bacteria
express
dsrna
result
specif
gene
silenc
nematod
feed
bacteria
hirlaki
tabara
craig
c
mello
groupmat
also
show
feed
soak
worm
dsrna
effect
way
gene
silenc
method
hold
promis
highthroughput
rnai
method
begin
creation
feed
strain
first
select
target
region
approxim
bp
correspond
mrna
link
plasmid
specif
structur
plasmid
transform
e
coli
rnase
iii
mutant
strain
express
dsrna
one
point
need
special
mention
effect
gene
silenc
liquid
cultur
medium
plate
feed
nematod
similar
depend
penetr
express
effici
howev
experiment
process
restrict
still
differ
similar
sirna
mirna
also
kind
small
noncod
rna
contain
nt
regul
gene
express
mrna
degrad
translat
inhibit
associ
differenti
homeostasi
diseas
mirna
alreadi
found
plant
anim
virus
conserv
plant
anim
mirna
regul
mrna
express
mirna
also
regul
regul
one
kind
regul
mirna
inhibitor
use
studi
function
mechan
endogen
mirna
mirna
inhibitor
mainli
divid
two
categori
natur
mirna
inhibitor
artifici
mirna
inhibitor
natur
mirna
inhibitor
compet
endogen
rna
cerna
viral
rna
mrna
pseudogen
rna
lncrna
circrna
competit
recogn
mirna
recognit
element
mre
reduc
inhibitori
effect
mirna
releas
target
mrna
cerna
model
describ
potenti
commun
network
among
transcript
provid
opportun
discov
novel
therapeut
target
human
cancer
mirna
highli
express
mani
diseas
inhibit
mirna
allevi
overrepress
target
mrna
restor
normal
cell
phenotyp
consid
promis
therapeut
strategi
differ
natur
one
artifici
mirna
inhibitor
exogen
rna
includ
antimirna
oligonucleotid
amo
mirna
spong
amo
singlestrand
short
rna
oligonucleotid
fulli
complementari
mirna
due
singlestrand
structur
easili
degrad
nucleas
chemic
modif
good
way
increas
affin
target
mirna
stabil
mirna
inhibitor
avoid
nucleas
degrad
prevent
cleavag
risc
promot
tissu
uptak
vivo
deliveri
barbara
robertson
colleagu
show
function
inhibitor
vari
posit
mismatch
inhibitor
seed
region
nucleotid
region
nucleotid
equal
import
determin
recognit
inhibitor
target
endogen
mirna
deep
research
amo
wide
use
mirna
lossoffunct
studi
mirna
suppress
therapi
howev
still
mani
shortcom
inhibit
develop
discoveri
inhibit
still
could
sustain
perman
amo
toxic
trigger
innat
immun
respons
final
caus
cell
death
concentr
amo
use
transfect
exert
satisfactori
inhibit
wherea
higher
concentr
may
caus
cell
death
mirna
spong
design
rna
transcript
express
strong
promotor
bind
target
mirna
competit
via
multipl
tandem
mirna
bind
site
differ
amo
mirna
spong
transfect
express
stabli
cell
play
prolong
even
perman
role
suppress
individu
mirna
whole
famili
mirna
spong
also
wide
use
mirna
lossoffunct
studi
mirna
suppress
therapi
kind
inhibitor
chemic
synthes
mirna
mimic
mirna
doublestrand
rna
cell
mirna
mimic
typic
retain
strand
chemic
modif
often
introduc
mirna
mimic
improv
stabil
select
exclud
passeng
strand
facilit
guid
mirna
load
risc
mirna
mimic
opposit
function
mirna
inhibitor
mirna
inhibitor
suppress
mirna
wherea
mirna
mimic
mimic
highlevel
express
endogen
matur
mirna
cell
enhanc
regul
endogen
mirna
power
tool
mirna
function
research
mirna
mimic
simpl
effici
transfect
cell
encapsul
transfect
reagent
without
need
construct
vector
without
fear
viru
protect
although
applic
doublestrand
mirna
mimic
promis
still
drawback
use
therapi
presenc
passeng
strand
add
complex
increas
need
synthesi
doubl
strand
also
may
result
potenti
offtarget
effect
caus
passeng
strand
doublestrand
rna
difficult
enter
cell
tissu
singlestrand
rna
often
requir
use
appropri
transport
vector
prosirna
recent
develop
approach
produc
pool
highli
efficaci
sirna
e
coli
like
chemic
synthes
sirna
mediat
gene
silenc
also
temporari
sirna
produc
e
coli
key
point
plasmid
consist
promotor
pair
invert
repeat
sequenc
encod
gene
interest
linker
design
transform
bacteria
protein
found
plant
rna
viru
tombusviru
stabil
sirna
bind
sequenceindepend
way
plasmid
transform
e
coli
invert
repeat
sequenc
transcrib
form
long
hairpin
rna
linker
coexpress
protein
process
rnase
iii
e
coli
hairpin
rna
digest
numer
sirna
combin
protein
form
complex
one
captur
complex
ni
bead
affin
interact
elut
sirna
purifi
hplc
plant
tombusviru
k
da
protein
rna
silenc
suppressor
protein
select
bind
exactli
match
doublestrand
antivir
sirna
nt
imperfectli
pair
mirna
ssrna
dsrna
express
e
coli
small
rna
speci
accumul
doublestrand
nt
length
like
eukaryot
sirna
name
bacteri
sirnalik
rna
prosirna
prokaryot
sirna
escherichia
coli
rnase
iii
belong
rnase
iii
endoribonucleas
famili
eukaryot
dicer
respons
gener
prosirna
rnase
iii
also
known
gener
nt
dsrna
vitro
method
reli
ectop
express
sirnabind
protein
found
plant
rna
viru
express
e
coli
stabil
nt
sirnalik
speci
produc
bacteri
rnase
iii
transfect
mammalian
cell
sirna
gener
bacteria
express
hairpin
rna
encod
nucleotid
target
gene
low
nanomolar
concentr
reproduc
knock
gene
express
without
immunogen
offtarget
effect
bacteri
produc
sirna
contain
multipl
sequenc
target
gene
especi
use
suppress
polymorph
cellular
viral
gene
sequenc
specif
rnai
lead
silenc
target
gene
express
associ
phenotyp
chang
appli
largescal
mechan
function
interrog
variou
organ
model
differ
speci
rnai
screen
provid
new
approach
understand
unknown
biolog
pathway
one
aspect
perform
highthroughput
genomewid
screen
help
identifi
possibl
regul
gener
process
hand
also
serv
limit
screen
help
narrow
crucial
factor
specif
pathway
rnai
screen
sequenc
specif
rnai
reagent
introduc
model
organ
caus
degrad
target
transcript
rnai
process
employ
nt
doublestrand
sirna
fragment
character
overhang
produc
cleavag
long
dsrna
type
iii
endornas
dicer
differ
cell
type
approach
deliveri
method
cellbas
rnai
screen
determin
setup
appropri
rnai
reagent
librari
model
lack
defens
type
interferon
respons
c
elegan
drosophila
long
dsrna
taken
intracellular
cleavag
activ
dicer
produc
highli
specif
overlap
sirna
pool
target
gene
mammalian
cell
introduct
exogen
long
dsrna
activ
antivir
type
interferon
respons
dsrnabind
protein
kinas
r
lead
disrupt
phenotyp
screen
order
minim
interferon
respons
reagent
pool
prepar
recombin
bacteri
rnase
iii
dicer
form
small
interf
rna
sirna
endoribonucleaseprepar
sirna
esirna
small
hairpin
rna
shrna
use
mammalian
cell
screen
rnai
reagent
escap
interferon
respons
defens
system
low
concentr
chemic
synthes
sirna
design
mimic
final
product
dicer
cleavag
chemic
modif
offer
superior
duplex
stabil
high
target
mrna
knockdown
effici
synthet
sirna
current
commerci
sirna
librari
avail
cover
complet
genom
sever
speci
librari
provid
three
sirna
sequenc
target
gene
reach
estim
silenc
effici
transfect
extend
protein
deplet
associ
phenotyp
chang
vari
due
differ
protein
lifetim
sirna
deliveri
transfect
ineffici
primari
cell
research
show
success
gene
silenc
primari
cell
requir
tenfold
higher
sirna
dosag
human
cervic
cancer
hela
cell
line
similar
result
observ
experi
aim
effici
knockdown
nfkappa
b
primari
human
dendrit
cell
critic
requir
nm
sirna
significantli
higher
usual
effect
dosag
nm
establish
cell
model
retrovir
lentivir
approach
suitabl
effici
knockdown
primari
cell
short
hairpin
rna
shrna
deliv
viral
transduct
continu
express
cell
mediat
stabl
gene
silenc
regardless
transfect
effici
sever
shrna
librari
also
avail
primari
cell
rnai
screen
rnai
screen
aim
highthroughput
detect
desir
phenotyp
defin
differ
setup
assay
array
screen
assay
use
multiwel
plate
contain
singl
rnai
reagent
separ
knockdown
experi
readout
array
screen
measur
specif
luciferas
fluoresc
indic
moreov
highcont
imagebas
readout
report
quantit
paramet
morpholog
chang
prolifer
viabil
apoptosi
cellular
function
individu
target
whole
popul
employ
specif
fluoresc
imag
label
sampl
highthroughput
measur
format
array
screen
assay
pool
screen
introduc
whole
set
rnai
librari
bulk
popul
cell
readout
pool
screen
requir
present
select
chang
cell
phenotyp
allow
rapid
analys
multipl
cell
type
offtarget
effect
rnaibas
screen
state
major
issu
respons
fals
discoveri
candid
differ
type
offtarget
effect
distinguish
variou
studi
exampl
sirna
share
ident
sequenc
unrel
mrna
undesir
silenc
would
produc
confus
phenotyp
result
fals
posit
event
addit
seed
region
sirna
duplex
weakli
complementari
sequenc
untransl
region
unrel
mrna
sirna
act
like
microrna
mirna
induc
undesir
mrna
degrad
translat
block
caus
nontarget
protein
deplet
mammalian
cell
introduct
short
sirna
fragment
sometim
sequenceindepend
activ
antivir
type
interferon
respons
caus
unpredict
fals
disturb
minim
offtarget
effect
nontarget
scrambl
rnai
sequenc
setup
control
differ
deliveri
method
sirna
monitor
evalu
multipl
sirna
speci
use
target
gene
mani
complex
phenotyp
display
vivo
level
analyz
cellbas
vitro
assay
avail
genom
transcriptom
sequenc
inform
vivo
rnai
make
possibl
research
perform
function
genom
studi
directli
model
organ
rnai
phenomenon
first
identifi
c
elegan
studi
found
rnai
c
elegan
systemat
herit
thu
variou
vivo
rnai
screen
conduct
c
elegan
provid
numer
new
understand
divers
biolog
process
age
obes
drosophila
anoth
popular
vivo
rnai
screen
model
wellannot
genom
multispecif
genet
modifi
tool
tissu
stage
specif
studi
perform
drosophila
abil
tissu
stage
specif
rnai
drosophila
allow
screen
embryo
larval
adult
well
idea
pool
rnai
screen
comparison
differ
cell
popul
ex
vivo
screen
introduc
pool
shrna
transfect
cell
mice
perform
exampl
inject
transduc
lymphoma
cell
vivo
context
abil
contribut
tumorigenesi
directli
assess
vivo
rnai
screen
provid
straightforward
quick
approach
screen
interest
phenotyp
tissu
stage
specif
manner
due
abil
specif
gene
silenc
gener
therapeut
target
mani
scientist
paid
much
attent
rnai
technolog
function
analysi
specif
gene
observ
variat
physiologicalbiochem
characterist
gene
silenc
also
discov
gene
involv
variou
diseas
cure
tradit
pharmaceut
approach
treat
diseas
medicin
target
compar
antisensebas
method
antisens
dna
oligonucleotid
ribozym
use
rnai
therapeut
applic
great
advantag
main
advantag
rnai
specif
theori
sequencespecif
sirna
design
watsoncrick
base
pair
interact
use
silenc
gene
without
restrict
whether
know
function
gene
regardless
protein
gene
express
structur
function
protein
high
specif
even
allow
sirna
map
mutat
site
differ
normal
allel
even
one
nucleotid
substitut
due
differ
sequenc
design
algorithm
target
sequenc
select
difficult
directli
compar
gene
silenc
efficaci
among
sever
technolog
certain
rnaimedi
inhibit
effici
antisens
oligonucleotid
antisens
oligonucleotid
develop
wide
use
gene
regul
vitro
vivo
past
decad
although
result
consist
rnai
mechan
inde
complet
differ
base
mechan
action
odn
classifi
two
group
one
rnasehdepend
oligonucleotid
result
degrad
mrna
stericblock
oligonucleotid
structur
suppress
progress
splice
translat
rnaseh
endoribonucleas
hydrolyz
phosphodiest
bond
rna
rnadna
duplex
target
region
mrna
inhibit
howev
stericblock
oligonucleotid
effici
aug
initi
codon
region
phosphorothio
oligonucleotid
may
alway
optim
site
target
furthermor
sirna
appear
potent
low
concentr
nm
resist
cell
cultur
mice
although
sirna
commonli
use
nowaday
seem
promis
therapeut
applic
due
specif
potenc
still
fraught
challeng
take
full
advantag
potenti
technolog
mani
intracellular
extracellular
barrier
need
overcom
stabil
offtarget
effect
immun
respons
sinc
sirna
exogen
molecul
success
transport
sirna
specif
gene
cell
tissu
exert
gene
silenc
activ
first
problem
solv
although
sirna
doublestrand
stabl
singlestrand
rna
still
quickli
degrad
nucleas
plasma
tissu
purpos
effort
made
chemic
modif
sirna
reduc
suscept
rnase
alter
pharmacokinet
properti
increas
halflif
vivo
sever
studi
shown
halflif
period
unmodifi
sirna
vivo
sever
minut
significantli
improv
protect
vehicl
chemic
modif
tabl
even
sometim
cost
reduc
activ
suppress
tabl
chemic
modif
sirna
stabil
optim
stabil
sirna
enter
cell
reach
target
site
make
gene
silenc
effect
becom
anoth
major
problem
offtarget
effect
sirna
inhibit
express
desir
gene
also
undesir
gene
may
lead
unpredict
genet
chang
sever
studi
show
offtarget
gene
regul
result
degrad
mrna
partial
ident
seed
region
sirna
sequenc
posit
nucleotid
end
guid
strand
bioinformat
studi
shown
seed
region
usual
found
utr
suggest
mirnalik
mechan
two
strategi
solv
offtarget
effect
mention
due
seed
region
straightforward
way
ensur
sequenc
complementari
seed
region
uniqu
target
gene
possibl
exist
theoret
level
option
mani
studi
shown
offtarget
effect
weaken
chemic
modif
seed
region
tabl
doublestrand
structur
sirna
recogn
foreign
innat
immun
system
although
sirna
toler
long
dsrna
case
also
trigger
immun
respons
past
two
decad
mani
studi
sirnainduc
interferon
respons
report
although
induct
ifn
usual
benefici
bodi
uncontrol
induct
innat
defens
mechan
harm
demonstr
sirna
duplex
induc
potent
ifnmedi
activ
upregul
tolllik
receptor
cell
typespecif
manner
even
make
cell
die
studi
systemat
analyz
sirna
capabl
induc
interferon
exampl
hornung
groupmat
identifi
specif
sequenc
nine
base
end
sens
strand
seem
relat
immunolog
activ
therefor
avoid
rnaiinduc
immun
respons
necessari
condit
use
rnai
therapeut
strategi
use
avoid
immun
stimul
includ
avoid
offend
sequenc
sirna
design
inactiv
offend
sequenc
chemic
modif
use
sirna
deliveri
strategi
first
strategi
still
feasibl
stimulatori
motif
identifi
howev
next
one
confirm
mani
studi
mammalian
cell
nucleotid
modifi
n
methyladenosin
n
methylguanosin
inosin
pseudouridin
mani
omethyl
nucleosid
thu
capac
activ
dendrit
cell
tlrexpress
cell
suppress
good
small
rna
play
silent
role
accur
transport
destin
therefor
ideal
deliveri
vector
stabl
effect
safe
specif
stabl
effect
carrier
ensur
small
rna
transport
cell
tissu
long
period
time
without
degrad
reach
target
site
safe
vector
bring
side
effect
organ
exert
gene
silenc
ideal
vector
need
abl
distinguish
target
gene
normal
gene
prevent
abnorm
bodi
treatment
anim
studi
far
viral
nonvir
vector
local
system
administr
use
achiev
efficaci
advantag
disadvantag
viral
approach
vs
nonvir
approach
viral
approach
provid
excel
tissuespecif
tropism
transduct
effici
singl
administr
could
lead
durabl
downmodul
target
suitabl
divid
cell
nondivid
cell
nonvir
vector
also
effici
lower
dose
need
nake
small
rna
help
form
complex
polyanion
nucleic
acid
interact
neg
charg
cell
membran
due
cation
natur
safer
viral
vector
simplic
use
possibl
largescal
product
viral
approach
induc
mutat
trigger
immunogen
inflammatori
respons
cost
highli
product
imposs
fulli
estim
drug
exposur
regard
amount
time
limit
load
capac
wherea
nonvir
approach
less
effici
gene
silenc
viral
vector
limit
abil
reach
cross
nuclear
membran
lipid
polym
cytotox
limit
use
deliveri
protein
antibodi
may
influenc
normal
function
produc
side
effect
biolog
activ
local
administr
vs
system
administr
clear
advantag
disadvantag
two
administr
one
chosen
entir
base
requir
principl
choos
two
method
dosag
need
target
site
possibl
effect
drug
nontarget
site
usual
dose
small
rna
need
local
administr
lower
system
administr
sinc
local
administr
appli
small
rna
near
target
tissu
system
one
circul
small
rna
around
whole
bodi
besid
possibl
effect
exposur
drug
nonspecif
tissu
also
consid
say
local
administr
might
prevent
undesir
effect
system
administr
mani
kind
modif
rna
usual
divid
three
major
categori
modif
overhang
termini
conjug
group
also
consid
kind
deliveri
method
modif
within
oligonucleotid
architectur
modif
special
databas
http
crddosddnetserverssirnamod
develop
chemic
modif
sirna
chemic
modif
optim
varieti
therapeut
problem
increas
silenc
potenc
improv
nucleas
resist
enhanc
halflif
inhibit
immunostimul
reduc
offtarget
effect
etc
howev
optim
one
problem
also
add
problem
consid
decid
kind
chemic
modif
want
use
year
clinic
develop
rnai
therapeut
begin
realiz
promis
multipl
diseas
area
includ
genet
mutat
viral
infect
cancer
mani
sirna
drug
fill
need
therapi
manipul
gene
implic
diseas
includ
previous
undrugg
gene
product
howev
bottleneck
clinic
applic
rnai
still
exist
lack
effect
sirna
deliveri
method
vivo
though
effect
approach
avail
deliv
sirna
cell
line
earli
day
rnai
develop
shown
sirna
system
administr
experiment
anim
hydrodynam
intravascular
inject
cholesterol
conjug
liposom
cellpenetr
peptid
variou
type
nanoparticl
howev
approach
practic
safe
applic
human
effici
earli
approach
typic
low
thu
larg
number
sirna
typic
ten
milligram
per
kg
requir
could
make
sirna
medicin
prohibit
expens
larg
dose
sirna
like
caus
undesir
sideeffect
includ
immun
activ
enabl
effici
deliveri
sirna
specif
tissu
across
cell
membran
hotli
pursu
area
research
sirna
deliveri
technolog
also
rapidli
evolv
mani
sirna
drug
alreadi
advanc
clinic
trial
recent
advanc
manufactur
lipid
nanoparticl
lnp
use
specif
chemic
conjug
revit
clinic
develop
sirna
drug
lipid
nanoparticl
typic
spheric
size
around
nm
diamet
much
smaller
commerci
cation
liposomebas
transfect
reagent
sever
hundr
nm
besid
advantag
size
featur
contain
cation
lipid
bind
neg
charg
sirna
also
make
lipid
nanoparticl
better
deliveri
vector
particular
alnylam
tekmira
two
lead
rnai
therapeut
compani
develop
new
gener
lnp
exceedingli
effici
deliv
sirna
liver
cell
intraven
administr
advanc
clinic
program
sirna
drug
patisiran
alnylam
patisiran
design
treat
transthyretin
ttr
mediat
amyloidosi
inherit
diseas
caus
genet
mutat
ttr
gene
patient
carri
mutat
ttr
gene
produc
misfold
ttr
protein
liver
aggreg
form
amyloid
fibril
tissu
peripher
nerv
heart
result
diseas
polyneuropathi
cardiomyopathi
progress
debilit
often
fatal
patisiran
compos
synthet
sirna
target
ttr
gene
deliv
lnp
led
knockdown
serum
ttr
protein
level
phase
ii
clinic
trial
patisiran
first
fda
approv
sirna
drug
market
anoth
import
area
sirna
therapeut
viral
infect
tradit
lack
effect
treatment
option
huge
impact
public
health
current
pandem
ebola
viru
west
africa
newli
discov
coronaviru
middl
east
highlight
urgent
need
effect
antivir
treatment
highli
infecti
emerg
virus
ebola
viru
sirna
drug
tkmebola
advanc
ebola
therapi
clinic
develop
phase
trial
tkmebola
mixtur
three
sirna
target
three
ebola
gene
deliv
lnp
shown
protect
monkey
deadli
ebola
infect
sirna
drug
also
develop
treat
chronic
hepat
b
viru
hbv
infect
diseas
preval
chines
popul
sirna
drug
develop
arrowhead
research
contain
hepatocytetrop
cholesterolconjug
sirna
target
hbv
coagul
factor
vii
deliv
dynam
poli
conjug
technolog
shown
promis
result
phase
clinic
trial
enter
phase
ii
clinic
trial
cancer
therapi
sirna
offer
quick
way
design
gene
target
person
therapi
base
rich
knowledg
cancer
biolog
oncogen
one
key
clinic
target
pololik
kinas
protein
involv
cell
cycl
regul
often
overexpress
tumor
cell
wellvalid
prooncogen
multipl
cancer
includ
colon
lung
cancer
cell
lnp
formul
sirna
therapi
tekmira
earli
clinic
trial
adrenocort
carcinoma
gastrointestin
neuroendocrin
tumor
hepatocellular
carcinoma
anoth
notabl
clinic
program
alnvsp
alnylam
compos
lnp
contain
two
differ
sirna
target
vascular
endotheli
growth
factor
vegfa
inhibit
tumor
angiogenesi
kinesin
spindl
protein
ksp
inhibit
tumor
mitosi
phase
clinic
trial
alnvsp
promis
result
show
sirna
deliv
tumor
sirnamedi
mrna
cleavag
vegfa
regress
liver
metastas
observ
patient
also
shown
version
three
galactos
molecul
galnac
link
end
sirna
enabl
bind
sirna
asgpr
receptor
surfac
hepatocyt
direct
sirna
go
liver
subcutan
administr
galnac
amino
sugar
deriv
galactos
affin
asgpr
galnac
greater
galactos
subcutan
administr
sirnagalnac
conjug
inhibit
express
target
mrna
liver
ligand
deriv
galnac
compat
solidphas
oligonucleotid
synthesi
deprotect
condit
synthesi
yield
compar
standard
oligonucleotid
optim
modifi
sirnagalnac
conjug
hepatotrop
longact
potenti
treat
wide
rang
diseas
involv
liverexpress
gene
lnp
galnac
approach
shown
safe
human
use
clinic
trial
summari
sirna
drug
use
target
diseas
liver
associ
deliveri
barrier
tissu
outsid
liver
remov
sirna
broad
rang
therapeut
applic
make
futur
rnai
therapeut
much
brighter
rnai
agricultur
industri
becom
excit
area
commerci
develop
rnai
mainli
use
tool
creat
genet
modifi
gm
plant
modif
offer
either
improv
agronom
trait
increas
surviv
biotic
abiot
stress
develop
resist
certain
damag
caus
pathogen
insect
parasit
creat
gm
crop
superior
agronom
trait
trend
topic
agricultur
develop
use
rnai
approach
improv
nutrit
valu
grain
yield
differ
crop
promis
cui
team
show
hairpin
rnamedi
gene
silenc
oleat
desaturas
gener
high
oleic
peanut
line
nutrit
level
peanut
oil
convent
qualifi
proport
oleic
linol
acid
oleat
desaturas
gene
neg
regul
high
oleic
acid
product
use
agrobacteriummedi
transform
gene
success
suppress
signific
increas
oleic
acid
content
observ
transgen
peanut
line
similarli
wheat
morel
group
found
starchbranch
enzym
encod
gene
sbeiia
sbeiib
relat
product
amylos
content
success
creat
transgen
wheat
line
use
rnai
techniqu
regul
express
sbeiia
sbeiib
transgen
wheat
obtain
high
level
amylos
product
variou
health
benefit
grain
yield
improv
research
shown
rnaimedi
transgen
rice
line
increas
seed
weight
moreov
semidwarf
transgen
rice
line
gener
rnai
suppress
target
ga
gene
origin
taller
rice
shown
increas
number
seed
per
panicl
larger
panicl
size
drought
crucial
impact
yield
qualiti
agricultur
product
combin
physiolog
understand
plant
rnai
techniqu
appli
help
develop
toler
drought
stress
differ
studi
huang
group
found
use
promot
drive
rnai
construct
effect
regul
farnesyltransferas
canola
modif
offer
decent
yield
protect
canola
drought
stress
addit
similar
effect
obtain
rice
receptor
ckinas
neg
regul
stomat
closur
relat
water
loss
liang
team
success
creat
transgen
rice
line
whose
gene
suppress
rnai
transgen
rice
line
show
great
toler
drought
stress
anoth
team
use
virusinduc
gene
silenc
method
suppress
express
proteinas
gene
transcript
factor
jmjc
gene
peanut
gm
peanut
proven
secur
product
yield
betterqu
water
deficit
stress
rnai
help
control
insect
pest
variou
studi
show
differ
insect
could
take
exogen
dsrna
wong
team
design
oral
deliv
sequenc
specif
dsrna
experi
induc
rnai
activ
select
kill
target
speci
oral
administr
dsrna
target
utr
gammatubulin
gene
select
kill
drosophila
price
gatehous
use
inplanta
produc
dsrna
feed
compon
success
silenc
differ
target
gene
sever
pest
speci
lepidoptera
coleoptera
experi
demonstr
potenti
develop
insectresist
plant
crop
line
nevertheless
differ
studi
identifi
western
corn
rootworm
wcr
diabrotica
virgifera
virgifera
lecont
special
coleopteran
speci
ingest
dsrna
diet
trigger
robust
rnai
activ
within
bodi
robert
group
show
transgen
corn
plant
engin
produc
wcr
dsrna
could
induc
signific
reduct
wcr
feed
damag
growth
chamber
assay
inplanta
express
wcr
dsrna
success
inhibit
growth
wcr
prevent
damag
transgen
corn
anoth
studi
identifi
cytochrom
gene
highli
correl
growth
cotton
bollworm
helicoverpa
armigera
larva
fed
plant
diet
modifi
express
specif
dsrna
show
retard
growth
follow
lead
promis
find
studi
control
dsrna
transmiss
host
plant
insect
make
feed
silenc
effect
inherit
etc
emerg
parasit
weed
major
caus
poor
crop
product
agricultur
rnai
signal
transmit
host
crop
parasit
examin
potenti
method
control
parasit
weed
yoder
group
transform
interf
hairpin
rnatarget
gu
gene
lettuc
use
hemiparasit
plant
triphysaria
versicolor
express
gu
report
gene
parasit
root
either
transgen
nontransgen
lettuc
gu
stain
triphysaria
root
attach
transgen
lettuc
show
respect
lower
gu
activ
transcript
quantif
confirm
signific
reduct
gu
mrna
level
result
suggest
sequenc
specif
silenc
signal
success
transmit
host
plant
parasit
plant
induc
suppress
target
gene
within
parasit
follow
idea
radi
colleagu
investig
rnai
transit
tomato
parasit
orobanch
orobanch
spp
broomrap
parasit
plant
subsist
attach
root
host
plant
caus
sever
damag
variou
crop
includ
tomato
growth
orobanch
strong
mannitol
accumul
observ
mannos
reductas
essenti
enzym
relat
mannitol
synthes
activ
radi
team
produc
transgen
tomato
line
stabl
bear
orobanch
aegyptiaca
rtpcr
quantif
show
level
endogen
mrna
orobanch
aegyptiaca
grown
transgen
tomato
significantli
reduc
current
studi
show
rnai
modif
target
either
gene
involv
pathogen
gene
essenti
pathogen
surviv
metabol
gene
associ
pathogen
resist
plant
immun
toxic
respons
help
develop
resist
pathogen
diseas
plant
past
decad
research
demonstr
fatti
acid
metabol
play
import
role
pathogen
relat
immun
respons
takatsuji
group
use
rnai
method
silenc
essenti
gene
respons
desaturas
activ
fatti
acid
genet
modifi
arabidopsi
soybean
produc
show
resist
multipl
pathogen
infect
yet
follow
studi
focus
fatti
acid
gene
famili
member
conduct
suppress
gene
enhanc
resist
magnaporth
grisea
observ
gm
rice
line
metabol
relat
investig
fritz
team
found
arabidopsi
flagellin
trigger
specif
mirna
express
downregul
toll
immun
defici
pathway
result
significantli
enhanc
innat
immun
defens
develop
resist
infect
differ
bacteri
fungal
tobacco
studi
demonstr
rnai
mediat
silenc
glutathion
stransferas
enhanc
immun
respons
develop
resist
black
shank
diseas
recent
agribiotech
compani
begin
test
feasibl
appli
synthet
sirna
directli
crop
achiev
desir
agricultur
trait
without
make
genet
modif
idea
creat
sirna
spray
similar
chemic
spray
directli
appli
surfac
plant
sirna
spray
approach
huge
advantag
gm
approach
easi
choos
differ
sirna
sequenc
target
variou
crop
gene
pathogen
elimin
lengthi
process
breed
gm
crop
addit
sirna
work
tempor
alter
crop
genom
help
allevi
public
sentiment
toward
gm
crop
caus
perman
environment
impact
